HBV Mutation Detail Information

> T1753V Search Result


Mutation Information
Mutation Site T1753V
Mutation Type Nucleotide level
Gene/Protein/Region Type BCP
Genotype/Subtype C
Country China
Literature Information
PubMed PMID 25281206
Disease Liver cirrhosis; Hepatocellular carcinoma
Published Year 2014
Journal Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases
Title Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
Author Ji X,Zhang Q,Li B,Du Y,Yin J,Liu W,Zhang H,Cao G
Evidence The interaction of rs2856718 AG+GG genotype with T1753V, a HCC-risk mutation, significantly reduced LC risk, with an OR of 0.26 (95% CI, 0.09-0.78); whereas the interaction of rs2856718 AG genotype with C1673T, a LC-risk mutation, significantly increased HCC risk, with an OR of 2.80 (95% CI, 1.02-7.66) in genotype C HBV-infected subjects. 

Contents
Description
Mutation Information Note
  • Gene/Protein/Region Type: Virus Gene (e.g. LMP-1) or Virus Protein (e.g. Rep 68) or Virus Region (e.g. S, X)
Literature Information Note
  • Evidence: sentence contains this mutation information in the citation